Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temoporfin I-PDT for Advanced Head and Neck Cancers
NCT01415986Phase 2Terminated
- Sponsor
- University of Arkansas
- Start
- Nov 2010
- Primary completion
- Aug 2011
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of temoporfin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Arkansas. Started Nov 2010; status: terminated.
02
Drugs
temoporfin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01415986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415986.